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Survivors of acute infection with the neurotropic JHM strain of mouse hepatitis virus develop a persistent infection of the
central nervous system associated with chronic ongoing demyelination. Persistence is characterized by viral RNA in the
absence of infectious virus. To associate persistence with possible immune evasion and/or replication defects, viral RNA
from brains of acutely and persistently infected mice was examined for mutations by reverse transcriptase–PCR. Sequences
analyzed included the encapsidation sequence (ECS), the transmembrane domains of the matrix (M) protein, and a cytotoxic
T cell (CTL) epitope within the nucleocapsid (N) protein. The ECS, present only on genomic RNA, revealed minimal variability
and was detected out to 120 days postinfection, suggesting low levels of replication. The M gene sequence also remained
stable during persistence despite random mutations during the acute phase. Although the N gene sequence exhibited the
greatest diversity, mutations were random and not selected for during persistence. A single exception was detected
comprising a prominent Pro to Ser substitution in a region of N not associated with any known regulatory or immune function.
Of the N gene mutations found within the CTL epitope in responder mice (H-2d), one resulted in reduced CTL recognition with
no evidence of antagonist activity. However, this mutation was also detected in nonresponder mice (H-2b), suggesting that
escape variants arising from CTL pressure play no role in establishing persistence in immunocompetent hosts infected as
adults. © 1998 Academic Press
INTRODUCTION
Central nervous system (CNS) infection with the neu-
rotropic JHM strain of mouse hepatitis virus (MHV)
(JHMV) in the CNS of mice causes an acute demyelinat-
ing panencephalomyelitis with virus replication in oligo-
dendroglia, astrocytes, ependyma, microglia, and, to a
lesser extent, neurons (Houtman and Fleming, 1996;
Kyuwa and Stohlman, 1990; Lane and Buchmeier, 1997).
Both humoral and cellular immune responses provide
protection and reduce viral titers; however, incomplete
viral clearance results in a persistent CNS infection as-
sociated with chronic ongoing primary demyelination.
Survivors of the acute infection harbor virus in the form of
viral RNA in astrocytes and oligodendrocytes; however,
infectious virus is not detectable (Erlich et al., 1987;
Fazakerley and Buchmeier, 1993). Although this impli-
cates the balance of the immune response and viral
replication as a critical parameter in determining suc-
cessful clearance during acute infection, the relative
contribution of immune and nonimmune factors in estab-
lishing persistence is unknown. Attempts to establish a
link among virus evolution, the immune response, and
persistence in the CNS as the site of infection are ham-
pered by both the inability to recover infectious virus
from animals after 21 days postinfection (pi; Erlich et al.,
1987) and the large RNA genome of 32,000 nucleotides
(nt; Lai and Cavanagh, 1997). Studies have therefore
largely focused on the multi-functional Spike (S) protein
as a major factor of MHV pathogenesis. The S protein is
the receptor ligand (Dveksler et al., 1991; Yokomori and
Lai, 1992) is associated with host cell specificity (Frana
et al., 1985), mediates fusion, and also contains both
neutralizing antibody (Collins et al., 1982; Wege et al.,
1988) and CTL epitope domains (Bergmann et al., 1996;
Castro and Perlman, 1995). Furthermore, neuroattenu-
ated viral phenotypes are associated with a hypervari-
able region known to contain deletions and point muta-
tions (Fleming et al., 1986; Parker et al., 1989). Although
other viral regulatory RNA sequences have been dem-
onstrated to be involved in persistence in vitro (Chen and
Baric, 1995, 1996), little is known about the potential
contributions of non-S protein sequences in establishing
CNS persistence in vivo (Houtman and Fleming, 1996).
To investigate the contribution of immune- or replica-
tion-mediated parameters in driving persistent infection,
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this study examines RNA variability within regions con-
stituting a dominant, protective cytotoxic T cell (CTL)
epitope in BALB/c (H-2d) mice and in regions critical for
viral assembly. The encapsidation sequences (ECS) on
genomic RNA (Fosmire et al., 1992) and RNA encoding
the membrane-spanning region of the matrix (M) protein
(Rottier et al., 1986) were chosen as candidate se-
quences to assess a role of mutations leading to re-
duced viral assembly. Whereas mutations in the amino-
terminal domain of the M protein may alter membrane
topology, potentially resulting in impaired viral assembly,
mutations in the ECS may lead to unstable interactions
with the nucleocapsid (N) protein during encapsidation.
A role of CTL escape was addressed by sequence anal-
ysis of a region encompassing the class I Ld-restricted
pN318-326 epitope (Bergmann et al., 1993a). The pivotal
role of CD81 CTL in protection and JHMV clearance from
the CNS is documented by CD8 depletion, adoptive
transfer, and immunization studies (Flory et al., 1993;
Stohlman et al., 1995; Williamson and Stohlman, 1990).
Recipients of adoptively transferred N protein-specific
CTL are protected from a lethal virus challenge presum-
ably via viral clearance in all cell types except oligoden-
drocytes (Stohlman et al., 1995). Minimal evidence of
persisting viral antigen and chronic ongoing demyelina-
tion in these mice, compared to infected untreated mice,
indicated that the temporal relationship between CTL
responsiveness and the level and site of replicating RNA
affects disease outcome. The emergence of CTL escape
mutants in symptomatic suckling C57BL/6 (H-2b) mice
nursed by immunized dams further substantiated a pro-
tective role of CTL (Pewe et al., 1996). However, as yet
there is no evidence of S protein CTL escape mutants
resulting from an acute JHMV infection of naive, adult
C57BL/6 mice (Adami et al., 1995; Rowe et al., 1997a).
The more conserved nature of the N protein (Parker and
Masters, 1990) predisposes it as a suitable target to
evaluate the role of CTL pressure, especially in light of
the dominant nature of the CTL response to a single
epitope (Bergmann and Stohlman, 1996; Bergmann et al.,
1993a) and the lack of overlapping antibody epitopes in
this region (Stohlman et al., 1994).
Analysis of viral RT-PCR products isolated from the
brains of mice infected out to 135 days revealed little
evidence of sequence variation in the ECS or membrane-
spanning regions of the M protein over time at either the
clonal or the bulk RNA population levels. By contrast, an
88-amino-acid (aa) sequence constituting the N protein
CTL epitope displayed random mutations throughout the
acute and persistent phases. None of the mutations
accumulated during persistence with the exception of a
single mutation resulting in a Pro to Ser substitution at aa
363, located carboxy-terminal to the epitope. Epitope
mutations occurred in both MHC class I and T cell
TABLE 1
Mutation Frequencies of JHMV ECS, M, and N Gene Sequences per 103nt
Viral sequencea
BALB/c C57BL/6 DBT cells (8 hpi)
Time
pib
Clones
seq.
Mutated
clones
Mut.
freq.c
Time
pib
Clones
seq.
Mutated
clones
Mut.
freq.c
Clones
seq.
Mutated
clones
Mut.
freq.c
ECS nt 20286–
20479
(151 bp) 6-A 10 0 0 6-A 8 0 0 10 2 1.3
60-A 13 1 0.5 6-B 3 0 0
60-B 10 1 0.7
90-B 10 0 0
M nt 67–418
(331 bp) 6-A 17 8 2.3 10 3 0.6
60-A 6 0 0
60-B 5 5 0.6
N nt 984–1250
(210 bp) 6-A 7 3 2.0 6-A 16 4 1.7 10 3 0.9
6-B 7 3 2.0 6-B 3 1 1.5
60-A 15 9 1.9 120-A 20 7 1.6
90-A 18 10 2.1
90-B 10 5 2.3
HPRT 60 10 0 0
a The length of viral fragments excluding the primer sequences is indicated in parentheses.
b Clones were sequenced from individual mice (A, B) at the indicated time point pi.
c Calculations exclude sequences composing the primers and mutations occurring at the same position in different clones.
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receptor (TCR) contact residues. One mutation resulted
in reduced recognition; however, no evidence for CTL
antagonistic function was detected. The low frequency of
this mutation, in addition to its occurrence in both re-
sponder BALB/c mice and mice not recognizing this
epitope, indicates that CTL-driven escape variants are
not a dominant mechanism for JHMV persistence in the
CNS of adult BALB/c mice.
RESULTS
The N protein gene exhibits higher variability than the
ECS or M protein gene during persistence
To evaluate defective assembly and CTL escape as
potential mechanisms contributing to viral persistence,
brains from JHMV-infected BALB/c and C57BL/6 mice
were analyzed for the presence of three distinct viral
RNA populations: the ECS located only on genomic
length RNA, M protein coding sequences comprising
trans-membrane domains spanning aa 1–117, and N pro-
tein coding sequences comprising aa 301–388, both of
which are found on genomic and subgenomic RNAs.
PCR products were amplified by reverse transcription–
polymerase chain reaction (RT-PCR) from individual mice
at 6, 60, 90, and 120 days pi (dpi), subcloned into the
pZERO sequencing vector, and 5–18 clones sequenced
per mouse. Selected samples were sequenced directly
using automated sequencing to reveal prominent muta-
tions. All three target sequences were detectable in
persistently infected, but not uninfected mice. Further-
more, all products were present in decreased amounts
compared to those present in acutely infected mice (data
not shown). To gauge the efficiency of cDNA synthesis
and the mutation frequency introduced by the RT-PCR
procedure, a 214-bp fragment comprising sequences
specific for the housekeeping enzyme HPRT was used
as an internal standard. Individual HPRT clones were
analyzed from brain cDNA of 60-day persistently infected
mice analogous to the viral sequences. Furthermore,
RNA extracted from JHMV-infected DBT cells was ana-
lyzed to compare samples following in vitro and in vivo
infection (Table 1).
Individual ECS clones from 6-day infected mice were
all wildtype (wt), and only 2 of 22 clones from 60-day
persistently infected mice had a single mutation, result-
ing in a mutation frequency of 0.6 3 1023 per nt (Table 1).
All 10 HPRT clones analyzed from a 60-day infected
mouse exhibited only the wt sequence (Table 1). The
ECS mutations at nt 20325 (C3T) and nt 20336 (C3T)
were located outside of the hairpin structure essential for
encapsidation (Fosmire et al., 1992) and therefore were
unlikely to result in a phenotype. Secondary structure
analysis performed for each of these mutants showed no
disruptions of the ECS. Furthermore, no mutations were
detected in 10 clones isolated from a 90-day persistently
infected mouse. By contrast, 2 of 10 ECS clones derived
from in vitro infection revealed T3C and A3G mutations
at nt 20322 and 20452, respectively. Similar to the in vivo
mutants, these mutants were also found not to affect
ECS secondary structure. Undetectable mutations in the
HPRT and the majority of ECS sequences indicated that
the error rate introduced by the RT-PCR procedure was
below 0.6 3 1023 per nt. Although these data suggest
that mutations arising following in vitro and in vivo infec-
tion may be due to random errors by the viral polymer-
ase, RT-PCR-induced errors cannot be ruled out due to
the limited sample size. However, it is evident that the
rare ECS-specific mutations cannot account for a loss of
encapsidation and virus maturation. The absence of mu-
tations within nt 20353–20421 may be significant as
changes in this stem–loop domain could destabilize the
ECS leading to a non–functional structure (Fosmire et al.,
1992).
The amino-terminal domain of the M protein was an-
alyzed for RNA sequence variations to detect changes in
membrane topology potentially resulting in impaired viral
assembly. Of 17 clones spanning nt 67–418 (aa 1–117), 8
carried variations at 6 dpi (Table 1). All clones contained
a silent A3G transition at nt 190 relative to the reported
wt sequence (Pfleiderer et al., 1986), which was also
present in the viral inoculate. In contrast to the ECS, the
M gene RNA domain exhibited variability with a mutation
frequency of 2.3 3 1023 per nt during the acute phase
(Table 1). As listed in Table 2, a high number of mutations
TABLE 2
Mutations Found in Viral RNA Encoding M Protein aa 1–117
during JHMV Infection
mRNA
time pia Clones nt mutationb aa mutationc
6-A M3 158G3 A 31 Gly3 Ser
274 T3 C 69 Val
372 T3 C 102Phe3 Ser
M7 95C3 T 10 Pro3 Ser
M8 149 T3 C 28Phe3 Leu
166A3 G 33 Ile3Met
342 T3 C 92 Ile3 Thr
M11, M13 267 T3 C 67 Ile3 Thr
M12 246 T3 C 60Leu3 Ser
M14 368 T3 C 101 Tyr3 His
M15 312 T3 A 82 Val3 Glu
398A3 G 111 Arg3 Gly
60-A M20-M25 None
60-B M30-M34 323 T3 C 86Phe3 Leu
a Clones were sequenced from individual mice (A, B) at the indicated
time point pi.
b nt numbering includes the leader RNA of gene 6.
c All sequences analyzed revealed a silent A3 G mutation at nt 190
(aa 41 Leu).
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(92%) resulted in aa changes with an apparent bias from
hydrophobic to polar or charged residues (72%). Al-
though all mutations were localized at different positions
within a mRNA population, their polar nature may lead to
instability in the membrane, thereby decreasing viral
progeny. However, analysis of 60-day persistently in-
fected mice from the same group revealed that none of
the original mutations accumulated (Table 1). Whereas a
conservative Phe3Leu mutation was found in all clones
of one mouse, only inoculate sequences were recovered
from a second mouse. Screening of uncloned PCR prod-
ucts from these mice, and an additional 2 mice at 90 dpi
and 4 mice at 135 dpi, revealed no further evidence for
prominent mutations. Analysis of the same sequence
from in vitro cultures also revealed mutations, although
no mutations coincided, again indicating a random na-
ture of the mutations with no selective pressure. Despite
the inability to exclusively attribute the source of muta-
tions to RT-PCR or the viral polymerase, relative stability
of the M coding region throughout persistent infection
suggests that these domains are also not contributing to
viral persistence.
A potential role for CTL escape mutants (Klenerman et
al., 1996; Pewe et al., 1996) within the 9-aa epitope
(APTAGAFFF) was examined by analysis of a 210-nt N-
specific fragment from brains of CTL responder BALB/c
mice 6, 60, and 90 dpi. To attribute mutations directly to
random viral evolution or to immune pressure, the same
RNA sequence was analyzed from brains of infected non
N protein CTL responder C57BL/6 mice. As CTL escape
in the form of antagonism only requires the presence of
small populations of mutant peptide to inhibit the CTL
response to parent virus (Klenerman et al., 1996), 10–17
clones were sequenced per timepoint from individual
mice. Cloned PCR products revealed sequence diversity
with mutation frequencies in the order of 2 3 1023 per nt,
which were independent of mouse haplotype or time pi
(Table 1). The distribution of mutations was random
throughout the sequence with 63% of mutations leading
to aa changes in the form of substitutions, stop codons,
or frameshifts (Fig. 1). As observed for the M and ECS
sequences, there was no evidence for the accumulation
of distinct mutations with time.
The only exception was a prominent C3T transition at
nt 1170 resulting in a Pro3Ser mutation at aa 363 in
clones from both BALB/c and C57BL/6 persistently in-
fected mice, suggesting haplotype-independent evolu-
tion (Fig. 1). This transition was clearly supported by
automated sequencing of uncloned PCR products using
dyedeoxy terminators (Fig. 2). Whereas the mutant RNA
population was undetectable 6 dpi, it was prominent to a
varying extent in individual mice 60 and 90 dpi, with a
FIG. 1. Distribution of mutations in the N region spanning nt 984–1250 (aa 301–388). Viral RNA from brains of BALB/c or C57BL/6 mice 6, 60, 90,
and 120 dpi was amplified by RT-PCR and individual clones analyzed for mutations. Symbols represent the groups of mice analyzed at different
timepoints; total numbers of individual clones sequenced per group are listed in parentheses. Mutated nt are underlined within the wt sequence and
respective mutations indicated together with the symbol representing the mouse group in which they occurred; numbers next to mutations indicate
the frequency at which the respective mutation was found in all isolates sequenced. Mutations leading to aa changes are indicated by the respective
substitution in boldface above the wt aa using the single-letter code; fr indicates frameshift mutations. Italicized nt indicate the primer sequences.
The CTL epitope comprising aa 318–326 is boxed.
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complete conversion evident in some individuals (Fig. 2).
Analysis of uncloned PCR products from seven addi-
tional mice at 135 dpi confirmed the presence of this
mutation as a major RNA population, suggesting a se-
lective advantage of this mutant during viral persistence.
However, this region of the N protein is not involved in
any known immune response or functional role in repli-
cation or assembly, making its relevance to viral persis-
tence difficult to interpret.
Persistence in BALB/c mice is not associated with
CTL escape mutants
Mutations within and adjacent to the CTL epitope
were identified rapidly following infection of individual
mice; however, there was no evidence for the prevalent
emergence or accumulation of mutations within or prox-
imal to the epitope (Fig. 1). Despite their limited number,
mutations within the sequence encoding the epitope
were specifically in peptide positions 2 and 9 affecting
class I binding (Corr et al., 1994) and positions 7 and 8
mediating TCR recognition (Bergmann and Stohlman,
1996). Previous analysis of the antigenicity of single aa
substituted peptides using both polyclonal and clonal
CTL populations revealed that the conservative
Phe3263Leu variant in position 9 enhanced CTL recog-
nition (Bergmann and Stohlman, 1996). By contrast, the
variant peptide containing the Phe3253Leu transition in
the subdominant TCR contact residue was recognized
less efficiently compared to the wt peptide by polyclonal
CTL (Fig. 3). Analysis at the clonal level further revealed
that the mutant was only recognized by a subset of CTL
(Fig. 3). Whereas CTL clone B11.4 did not distinguish
between wt and variant peptide, clone B21.4 exhibited
minimal recognition of the variant peptide. Limited cytol-
ysis by the polyclonal population therefore most likely
reflects recognition by a subset of N-specific CTL re-
sponders. Loss of recognition was even more drastic
following endogenous expression of an 88-aa N protein-
derived fragment comprising the variant Phe3253Leu
epitope using recombinant Sindbis viruses (rSIN) (Fig. 4).
This severe reduction in recognition may be due to
FIG. 2. Emergence of a dominant mutation leading to a Pro3633 Ser
substitution during persistence. RNA spanning nt 984–1250 (aa 301–
388) of the N gene was amplified by RT-PCR from brains of BALB/c 6,
60, and 90 dpi. Automated sequencing was performed on bulk PCR
products using the 39 oligonucleotide JN1250. The sequence depicts 20
nt of the (2) sense (nt 1180–1160) strand showing the G3 A mutation
(C3 T in the sense strand) at position 1170; the arrowhead highlights
the mutated position.
FIG. 3. Differential recognition of a mutated CTL epitope by N-specific CTL. N-specific polyclonal CTL and two CTL clones B11.4 and B21.4 were
assayed for recognition of J774.1 target cells incubated with wt pN peptide (APTAGAFFF) or the Phe3253Leu mutant peptide (APTAGAFLF) at
concentrations ranging from 0.1 pM to 1 mM. Polyclonal CTL were tested at an E:T ratio of 30:1 and clones at 5:1.
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altered processing mediated by the amino acid ex-
change, a phenomenon demonstrated to result in
epitope destruction and lack of presentation (Ossendorp
et al., 1996). These data suggest that the Phe3253Leu
mutation is unlikely to have biological consequences, as
it not only triggers a subset of CTL, but also results in
poor presentation. Furthermore, as this mutation was
only detected in a minority of PCR clones, it would only
have the potential to dampen the overall CTL response
via an antagonistic mechanism (Klenerman et al., 1996).
However, inhibition of CTL function was never detectable
using either a range of variant peptide concentrations
(0.1 pM to 100 nM) in the presence of limiting wt peptide
concentrations or coexpression of both epitopes in rSIN-
infected cells in at least four separate experiments.
These data suggested that an antagonistic effect in the
presence of wt peptide was unlikely. Furthermore, se-
quence analysis of PCR products obtained from C57BL/6
mice, which do not mount a CTL response to the N
epitope, revealed an identical Phe3253Leu mutation at
120 dpi and an additional Phe3253Cys mutation in the
dominant TCR contact residue at 6 dpi (Fig. 1), suggest-
ing that epitope mutations found in BALB/c mice were
not CTL driven.
DISCUSSION
The extent to which MHV genomes evolve into quasi-
species and the relevance of viral evolution for the per-
sistent state is not well understood. Characteristics as-
sociated with in vitro persistence are selection of virus
variants with distinct fixed mutations and evolution of
more virulent phenotypes (Chen and Baric, 1995, 1996;
Gombold et al., 1993). Furthermore, mutation frequencies
and the rate at which mutations become fixed appear to
vary in different genomic positions (Chen and Baric,
1995). The selection of specific mutations in vivo is less
apparent and dependent on the model of JHMV infection
(Adami et al., 1994; Pewe et al., 1996; Rowe et al., 1997a).
Based on sequence analysis of CNS-derived viral RNA,
this report suggests that mutations in the ECS, N, and M
genes are infrequent and therefore unlikely to contribute
to viral persistence. Although random mutations were
detected during acute and persistent infection, there was
little evidence for the selection of fixed mutations with
time pi and a significant proportion of cDNA clones
retained the wt sequence (Table 1). The highest se-
quence heterogeneity was detected within the N gene,
which is contained within the genomic and all sub-
genomic RNA species (Lai and Cavanagh, 1997). Heter-
ogeneity may be attributed to the fact that the N se-
quence is the most abundant RNA population in infected
tissue, rather than to a higher intrinsic error frequency in
this region. Indeed, sequence comparison of the N
genes of several MHV strains show it is highly con-
served (Parker and Masters, 1990). Little variability in the
ECS during acute infection further suggested that the
viral genome may exhibit less heterogeneity than sub-
genomic mRNA, again possibly reflecting the relative
amounts of these RNA subsets (Lai and Cavanagh, 1997).
High mutation frequencies during acute infection with no
evidence of increasing mutations with time pi support
this notion. Alternatively, the N and M genes may allow
more flexibility in accommodating mutations than the
ECS without compromising functionality.
N gene variability was similar to observations reveal-
ing viral RNA mutation frequencies of 0.5 3 1023 to 5 3
1023 per nt in the N and S genes derived from C57BL/6
mice persistently infected with JHMV variant 2.2v-1
(Adami et al., 1995). These mice, in contrast to our find-
ings, exhibited increasing mutation rates with time pi in
both the N and the S genes (Adami et al., 1995), indicat-
ing that viral RNAs may diverge in the prevalence and
areas of mutations depending on individual JHMV vari-
ants. This is supported by the emergence of mutations
almost exclusively in the dominant S protein CTL epitope
in JHMV-infected suckling mice (Pewe et al., 1996, 1997),
in which maternal antibody affords limited protection and
disease onset is delayed and progressive (Perlman et al.,
1987). Minimal sequence variability outside of the CTL
epitope or within the M gene of these suckling mice
supports our data indicating that persistence is not
driven by randomly diverging viral RNA populations. It is
further noted that mutation frequencies based on PCR-
amplified products include errors introduced by the viral
polymerase, the reverse transcriptase, and the Taq poly-
merase (Smith et al., 1997). The number of sporadic
substitutions is also influenced by the initial concentra-
tion of template (Smith et al., 1997), which is very low in
RNA from persistently infected tissue (Fleming et al.,
1994). These variables add to the complexity already
provided by JHMV variants and their tropism in interpret-
FIG. 4. Effect of the Phe3253Leu substitution on presentation of
endogenously expressed antigen. N-specific polyclonal CTL were
tested for recognition of P815 cells infected with rSIN expressing aa
301–388 of the wt N protein (SIN-N301–388), the corresponding fragment
carrying the mutation (SIN-N301–388/325L), or no insert (SINwt).
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ing the biological significance of mutations in persis-
tently infected mice.
A role of antibody-mediated immune pressure in alter-
ing viral tropism and virulence has clearly been demon-
strated (Fazakerley et al., 1993; Fleming et al., 1986). By
contrast, a potential association between CTL escape
and the establishment of persistence has only recently
been suggested by analysis of infected suckling mice
(Pewe et al., 1996, 1997). Our data suggest that although
CTL constitute a major mechanism of JHMV clearance,
persistence in adult BALB/c mice is not associated with
CTL escape mutants. This finding is supported by the
absence of mutations within the S protein CTL epitope
sequence following infection of adult C57BL/6 mice
(Adami et al., 1995). Furthermore, although a variable
number of deletions within the S gene constituting the
CTL epitope domain were revealed in persistently in-
fected mice (Rowe et al., 1997a), these only comprised
approximately 5 % of sequences analyzed and appeared
to result from high-frequency RNA recombination rather
than immune pressure (Rowe et al., 1997b). The possi-
bility that the lack of CTL epitope variants in these mice
may be due to preferential viral replication in oligoden-
drocytes, which are more resistant to CTL than astro-
cytes and microglia (Stohlman et al., 1995), is diminished
by the observation that S protein-specific CTL in C57BL/6
mice infected with variant 2.2v-1 are comparable to those
induced by JHMV (Hinton, unpublished data). Numerous
S protein CTL epitope mutations found in infected suck-
ling mice nursed by immunized dams contrast these
observations (Pewe et al., 1996). These opposing results
may be attributed to considerable differences between
the JHMV model analyzed in this report and the maternal
antibody-protected suckling mouse model. In addition to
the protective role of maternal antibody, differences re-
side in the young age of mice, the delayed disease
onset, and the chronic progressive nature of the disease
in the suckling mice. These parameters most likely result
in altered kinetics and nature of immune responsiveness
in the differing models. The fact that epitope mutations
emerge in diseased suckling mice, which are carriers of
infectious JHMV, but not in asymptomatic infected mice,
supports the notion that CTL escape is driven by high
antigen load. Similar to other viruses, CTL escape mu-
tants of JHMV may therefore primarily evolve in persis-
tent infections associated with ongoing virus release
(Klenerman et al., 1996). However, the emergence of
escape mutants as early as 10–12 dpi, preceding clinical
disease by at least 1 week (Pewe et al., 1997), suggests
that the relative kinetics of CTL activation and virus
replication in individual mice plays a more critical role.
Lastly, the more conserved nature of the N protein itself
may also restrict N epitope variability (Parker and Mas-
ters, 1990).
In summary, persisting JHMV RNAs may diverge in the
prevalence and areas of mutations depending on JHMV
variants and murine infection (Adami et al., 1995; Pewe et
al., 1996; Rowe et al., 1997a). However, our results to-
gether with studies by Adami et al. (1995) and Rowe et al.
(1997a) suggest that adult mice surviving the acute in-
fection appear to be characterized by the absence of
dominant mutations in the ECS, S, M, and N sequences
analyzed to date. The diverse and random nature of
mutations found in survivors of acute JHMV infection may
reflect a multitude of attenuated genomes giving rise to
an overall low replication phenotype; alternatively, it may
reflect the sum of individually dominant mutations local-
ized to different foci of persistent infection. Heterogeneity
of viral quasispecies in different areas of the same target
tissue has been documented for HIV (Cheynier et al.,
1995). The size of the MHV genome and complexity of
mutations predict that persistence in vivo may be driven
by factors affecting cell tropism and replication as well
as immune responses. Attenuated replication as a po-
tential mechanism of persistence is favored by our find-
ing of an accumulative dominant mutation in the N pro-
tein during persistence in two differing mouse strains.
This domain does not contain CTL, T helper, or antibody
epitopes (Bergmann and Stohlman, 1996; Stohlman et al.,
1994; Van der Veen, 1996). The Pro3633Ser mutation
may, however, have deleterious consequences on pro-
tein folding and/or regulatory functions exhibited by the
N protein via differential phosphorylation (Lai and Ca-
vanagh, 1997; Stohlman et al., 1983).
MATERIALS AND METHODS
Mice, viruses, and cell lines
Male BALB/c (H-2d) and C57BL/6 (H-2b) mice were
obtained from the Jackson Laboratories (Bar Harbor, ME)
and housed in isolator cages. Mice were infected at
6–7 weeks of age intracranially with plaque-purified
JHMV-DS (Stohlman et al., 1982) using 300 PFU for
C57BL/6 and 600 PFU for BALB/c mice. This dose re-
sulted in 50% fatalities 7 to 9 dpi. rSIN expressing 88-aa
peptides constituting either the wt (SIN-N301–388) or the
variant N epitope (SIN-N301–388/325L) were generated us-
ing infectious mRNA transcribed from plasmid templates
as described previously (Hahn et al., 1992). The parent
vector, designated pTE392J, was kindly provided by
Charles Rice (Washington University School of Medicine,
St. Louis, MO). A modified version in which the original
XhoI site was replaced by a NotI site was used to
generate all rSIN viruses. Minigenes encoding N protein
aa 301–388 were amplified from their respective se-
quencing vectors using primers JN984 and JN1250 (de-
scribed below), digested with NcoI/KpnI, and subcloned
into compatible sites of vaccinia virus vector pK (Berg-
mann et al., 1993b). The fragments were reisolated by
digestion with SalI and EcoRI and subsequently sub-
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cloned into pBluescript II KS (Stratagene, La Jolla, CA).
The final vectors pTE-N301–388 and pTE-N301–388/325L were
generated by digesting the pBluescript derivatives with
XbaI (in the pBluescript polylinker) and NheI (derived
from the pK polylinker) and inserting the N fragments into
the unique XbaI site of plasmid pTE392J. Sequence anal-
ysis using pTE392J-specific primers pTE59 (GGG CCC
AGG TAG ACA ATA TTA C) and pTE 39 (GCGGTA AGC
GGG GAT CTA ATG) confirmed correct orientation and
sequence. Infectious RNA was produced by transcription
of 200–500 ng NotI linearized plasmid in 10 ml buffer
containing 40 mM Tris–HCl, pH 7.6, 6 mM MgCl2, 2
mM spermidine, 4 mM rNTPs, 20 mM cap analog
7mG(59)ppp(59)G (New England Biolabs, Beverly, MA),
0.5 mg/ml BSA, 10 U RNasin, and 5 U SP6 RNA polymer-
ase for 1 h at 37°C. Viral stocks were generated by
liposomal transfection of BHK-21 cells using RNA in
DOTAP (Boehringer Mannheim, Germany). Culture su-
pernatants were harvested at 36 h posttransfection, ali-
quots stored at 280°C and virus titers determined by
plaque assay on BHK-21 monolayers.
The J774.1 macrophage (H-2d), P815 thymoma (H-2d)
and BHK cell lines were propagated in DMEM containing
8% FCS.
CTL assays
Polyclonal N-specific CTL were generated from
splenocytes of JHMV immunized mice and stimulated in
the presence of 1 mM pN318-335 peptide as described
(Bergmann et al., 1993a). CTL clones were derived by
limiting dilution and propagated as described (Stohlman
et al., 1993). Cytolytic activity was measured in 51Cr
release assays as described (Bergmann and Stohlman,
1996; Bergmann et al., 1993a). Antigenicity of peptides
was tested on labeled J774.1 target cells using N-specific
T cell clones and uncloned N-specific CTL populations at
the indicated effector to target ratios (E:T). Peptide
pN318-326 (APTAGAFFF) and the derivative (APTA-
GAFLF) were purchased from Chiron Mimotopes (Clay-
ton, Australia). P815 cells were infected with rSIN at a
multiplicity of infection of 10 for 5 h at 37°C prior to
labeling. Data are expressed as percentage specific
lysis defined as 100 3 [(experimental lysis) 2 (sponta-
neous lysis)]/[total (detergent lysis) 2 (spontaneous ly-
sis)]. Maximum spontaneous release values were al-
ways ,25% of total release values.
RNA extraction and RT-PCR analysis
Brains were removed at the indicated time points and
one brain half per mouse was disrupted in a Tenbrock
homogenizer containing 2 ml guanidinium isothiocya-
nate solution (Cua et al., 1995). The suspension was
overlaid on 2.5 ml of a 5.4 M CsCl cushion and centri-
fuged at 30 K for 18 h at RT in a Beckman SW50.1 rotor.
RNA pellets resuspended in DEPC-treated water, quan-
titated, and aliquots were stored in 70% ethanol. Prior to
reverse transcription, 2 mg total RNA and 1 mg random
primer (Promega, Madison, WI) were mixed, heat dena-
tured for 5 min at 72°C, and then chilled on ice. Synthesis
of cDNA was then carried out for 60 min at 42°C in 25 ml
buffer containing 50 mM Tris–HCl (pH 8.3), 10 mM MgCl2,
50 mM KCl, 0.5 mM spermidine, 10 mM DTT, 0.4 mM
dNTPs, 14 U RNasin, and 10 U AMV-reverse transcrip-
tase (Promega). The cDNA was amplified using primers
ECS59 (ATT TTG GTT TGC TAT GCG TAG AG) and ECS39
(ATC GAG GTG AGA AAG AGG AC) spanning ECS nt
20286–20479 (Fosmire et al., 1992); JN984 (5-CCC GCT
AGC CAT GGT AAA GCT TGG AAC TAG TGA TCC) and
JN1250 (ACA GGT ACC TAC ATC TGC ACC ACC ATC
TTG) spanning N gene nt 984–1250 (Skinner and Sidell,
1983); and JM67 (TTA TGA GTA GTA CCA CTC AGG CC)
and JM418 (GCT CCA CCA GCT ACC AGT CC) spanning
M gene nt 67–418 (Pfleiderer et al., 1986). A 214-bp
fragment comprising sequences specific for the house-
keeping enzyme hypoxanthine phosphoribosyltrans-
ferase (HPRT) was used as an internal standard for
cDNA synthesis and sequence analysis; HPRT-specific
primers were 59 GTA ATG ATC AGT CAA CGG GGG AC
and 39 CCA GCA AGC TTG CAA CCT TAA CCA (Murphy
et al., 1993). Amplification was carried in 35–40 cycles
using 20–50% of the RT mixture in buffer containing 10
mM Tris–HCl (pH 8.3), 2 mM MgCl2, 50 mM KCl, 0.1 mM
dNTPs, 0.25 mg of each primer, and 1.25 U AmpliTaq DNA
polymerase (Perkin–Elmer, Branchburg, NJ). Oligonucle-
otides were purchased from Genosys Biotechnologies
(The Woodlands, TX).
cDNA cloning, sequencing, and RNA structure
analysis
PCR products were purified using GeneClean (BIO 101,
Inc., Vista, CA) and subcloned using the ZERO Back-
ground cloning kit (Invitrogen, San Diego, CA). Viral in-
serts were directly sequenced in both orientations by the
Sanger dideoxy chain termination method using Seque-
nase enzyme 2.0 (Sequenase DNA Kit Version 2.0, U.S.
Biochemicals) and flanking T7/SP6 primers. Some sam-
ples were sequenced using the dsDNA cycle sequenc-
ing system (Gibco BRL, Gaithersburg, MD) following PCR
amplification of the insert with SP6/T7 primers. Bulk PCR
products were directly analyzed by automated sequenc-
ing using dyedeoxy terminators and virus-specific prim-
ers (USC Norris Cancer Center Microchemistry Core
Laboratory). RNA secondary structure analysis was per-
formed using RNADraw (authored by Ole Matzura) which
was imported directly from the Vienna RNA package
(Hofacker et al., 1994).
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